Background: This is a multi-center cross-sectional epidemiological study to estimate the prevalence (%) of patients with elevated Lp(a) in patients with established CVD defined by their medical history. One study visit is planned for data collection. Relevant medical history and laboratory values for LDL-cholesterol (LDL-C) and Lp(a) within a past pre-specified period will be collected retrospectively. In case laboratory data are not available, blood sampling will be performed. Trial Registration No: NCT03887520 (clinicaltrials.gov) Link Sponsor: Novartis Pharmaceuticals Trial Status: Recruitment stopped Enrolling Centers: Worldwide: 45000 participants Core Study Team Basel:
© Christian Mueller, 2012 - 2020 │ DisclaimerImprintWebmaster │ Last Update: September 2020
Dr. Pedro Lopez Ina-Maria Ferel, Ph.D.
Heritage Lipoprotein(a)